ULVAC,Inc.JP:6728

Market cap
¥358.2B
P/E ratio
16.6x
Jun 30,
2013
Jun 30,
2014
Jun 30,
2015
Jun 30,
2016
Jun 30,
2017
Jun 30,
2018
Jun 30,
2019
Jun 30,
2020
Jun 30,
2021
Jun 30,
2022
Jun 30,
2023
Jun 30,
2024
Net sales163,351173,878179,174192,437231,831249,271220,721185,402183,011241,260227,528261,115
Cost of sales126,389131,231135,710141,314168,001176,163155,845134,805129,247167,517160,366180,455
Gross profit (loss)36,96242,64643,46451,12263,82973,10864,87650,59653,76473,74367,16280,660
Selling, general and administrative expenses30,84730,65132,33133,25934,36137,75741,04734,63836,56743,68247,21750,890
Selling expenses13,18613,70714,97815,74014,81815,70318,21713,09114,80118,03617,89320,840
General and administrative expenses17,66116,94417,35317,51819,54322,05422,83021,54721,76625,64629,32430,050
Selling, general and administrative expenses30,84730,65132,33133,25934,36137,75741,04734,63836,56743,68247,21750,890
Operating profit (loss)6,11511,99611,13217,86429,46835,35123,82815,95817,19730,06119,94629,771
Interest income169216181113117157183171199248394522
Dividend income173267310251302470687634650745429574
Rental income--333360297300296-----
Foreign exchange gains1,226765743578-352---571--
Other1,0501,1101,7631,0198318161,5791,7471,7421,3121,5791,060
Share of profit of entities accounted for using equity method17-1282992034263464945698612,661495
Non-operating income3,1203,6993,8182,6191,7502,6312,8163,5113,1603,7365,0632,989
Other1,0501,1101,7631,0198318161,5791,7471,7421,3121,5791,060
Non-operating income3,1203,6993,8182,6191,7502,6312,8163,5113,1603,7365,0632,989
Interest expenses1,5621,2571,038797511349293437498410441507
Foreign exchange losses--------373-5741,386
Commission for syndicated loans-198365244170-139--195287-
Foreign exchange losses--------373-5741,386
Other1,4099457101,0709927277769801,5209948261,081
Commission for syndicated loans-198365244170-139--195287-
Non-operating expenses2,9712,3112,4752,1101,5031,0761,0691,4182,3911,5982,1282,975
Other1,4099457101,0709927277769801,5209948261,081
Non-operating expenses2,9712,3112,4752,1101,5031,0761,0691,4182,3911,5982,1282,975
Ordinary profit (loss)6,26413,38412,47518,37329,71636,90725,57518,05217,96632,20022,88029,785
Gain on sale of investment securities----812,0021,7103,2614,998343-155
Gain on sale of shares of subsidiaries and associates-83828------797--
Gain on sale of non-current assets1051,0683266035-7547555915394
Extraordinary income2832,4713543011172,0022,0883,3085,0531,199153249
Extraordinary income2832,4713543011172,0022,0883,3085,0531,199153249
Impairment losses---31--331175-3,0902,311217
Cost to deal with COVID-19--------9841,028--
Extraordinary losses7,1127181768881,0653825152391,4604,1182,311520
Profit (loss) before income taxes-56515,13712,65417,78628,76838,52727,14821,12221,55929,28020,72229,515
Income taxes - current2,3472,8053,1833,8924,5567,3096,7094,7904,8677,5496,1007,401
Income taxes - deferred202313-3,433-1,599-5,9374514,5961,218290542565
Income taxes2,5492,8083,1964592,9571,3727,1609,3866,0857,8396,6427,966
Profit (loss)--9,45817,32725,81137,15519,98811,73615,47421,44114,08021,549
Profit (loss) attributable to non-controlling interests--5846291,3421,2501,3239676441,231-891,316
Profit (loss) attributable to owners of parent--8,87416,69824,46935,90418,66510,76914,83020,21114,16920,233